Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myeloma
Related studies linked through entity extraction aliases.
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- N/A
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE2
Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Imageguided Theranostics in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
African American Cancer Clinical Trial Decisions: Testing Tailored Messages
- Status
- COMPLETED
- Phase
- NA
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
- Status
- COMPLETED
- Phase
- PHASE3
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)
- Status
- TERMINATED
- Phase
- NA
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
- Status
- COMPLETED
- Phase
- PHASE1
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
- Status
- TERMINATED
- Phase
- PHASE1
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2